Phosphatase inhibitor-1 (I-1) is a distal amplifier element of β-adrenergic signaling that functions by preventing dephosphorylation of downstream targets. I-1 is downregulated in human failing hearts, while overexpression of a constitutively active mutant form (I-1c) reverses contractile dysfunction in mouse failing hearts, suggesting that I-1c may be a candidate for gene therapy. We generated mice with conditional cardiomyocyte-restricted expression of I-1c (referred to herein as dTGI-1c mice) on an I-1–deficient background. Young adult dTGI-1c mice exhibited enhanced cardiac contractility but exaggerated contractile dysfunction and ventricular dilation upon catecholamine infusion. Telemetric ECG recordings revealed typical catecholamine-induced ventricular tachycardia and sudden death. Doxycycline feeding switched off expression of cardiomyocyte-restricted I-1c and reversed all abnormalities. Hearts from dTGI-1c mice showed hyperphosphorylation of phospholamban and the ryanodine receptor, and this was associated with an increased number of catecholamine-induced Ca2+ sparks in isolated myocytes. Aged dTGI-1c mice spontaneously developed a cardiomyopathic phenotype. These data were confirmed in a second independent transgenic mouse line, expressing a full-length I-1 mutant that could not be phosphorylated and thereby inactivated by PKC-α (I-1S67A). In conclusion, conditional expression of I-1c or I-1S67A enhanced steady-state phosphorylation of 2 key Ca2+-regulating sarcoplasmic reticulum enzymes. This was associated with increased contractile function in young animals but also with arrhythmias and cardiomyopathy after adrenergic stress and with aging. These data should be considered in the development of novel therapies for heart failure.
Katrin Wittköpper, Larissa Fabritz, Stefan Neef, Katharina R. Ort, Clemens Grefe, Bernhard Unsöld, Paulus Kirchhof, Lars S. Maier, Gerd Hasenfuss, Dobromir Dobrev, Thomas Eschenhagen, Ali El-Armouche
Title and authors | Publication | Year |
---|---|---|
Metabolic Communication by SGLT2 Inhibition.
Billing AM, Kim YC, Gullaksen S, Schrage B, Raabe J, Hutzfeldt A, Demir F, Kovalenko E, Lassé M, Dugourd A, Fallegger R, Klampe B, Jaegers J, Li Q, Kravtsova O, Crespo-Masip M, Palermo A, Fenton RA, Hoxha E, Blankenberg S, Kirchhof P, Huber TB, Laugesen E, Zeller T, Chrysopoulou M, Saez-Rodriguez J, Magnussen C, Eschenhagen T, Staruschenko A, Siuzdak G, Poulsen PL, Schwab C, Cuello F, Vallon V, Rinschen MM |
Circulation | 2023 |
Integrative human atrial modelling unravels interactive protein kinase A and Ca2+/calmodulin-dependent protein kinase II signalling as key determinants of atrial arrhythmogenesis
Ni H, Morotti S, Zhang X, Dobrev D, Grandi E |
Cardiovascular Research | 2023 |
Emerging Antiarrhythmic Drugs for Atrial Fibrillation
A Saljic, J Heijman, D Dobrev |
International journal of molecular sciences | 2022 |
Serine-threonine protein phosphatase regulation of Cx43 dephosphorylation in arrhythmogenic disorders
X Ai, J Yan, S Pogwizd |
Cellular Signalling | 2021 |
Molecular noise filtering in the β-adrenergic signaling network by phospholamban pentamers
Koch D, Alexandrovich A, Funk F, Kho AL, Schmitt JP, Gautel M |
Cell Reports | 2021 |
Preclinical evidence for the therapeutic value of TBX5 normalization in arrhythmia control
FS Rathjens, A Blenkle, LM Iyer, A Renger, F Syeda, C Noack, A Jungmann, M Dewenter, K Toischer, A El-Armouche, OJ Müller, L Fabritz, WH Zimmermann, LC Zelarayan, MP Zafeiriou |
Cardiovascular Research | 2020 |
Current Landscape of Heart Failure Gene Therapy
JM Kieserman, VD Myers, P Dubey, JY Cheung, AM Feldman |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2019 |
Age-Dependent Protein Expression of Serine/Threonine Phosphatases and Their Inhibitors in the Human Cardiac Atrium
U Gergs, T Trapp, H Bushnaq, A Simm, RE Silber, J Neumann |
Advances in Medicine | 2019 |
Rearrangement of the Protein Phosphatase 1 Interactome During Heart Failure Progression:
DY Chiang, KM Alsina, E Corradini, M Fitzpatrick, L Ni, SK Lahiri, J Reynolds, X Pan, L Scott, AJ Heck, XH Wehrens |
Circulation | 2018 |
AAV-9 mediated phosphatase-1 inhibitor-1 overexpression improves cardiac contractility in unchallenged mice but is deleterious in pressure-overload.
Schwab DM, Tilemann L, Bauer R, Heckmann M, Jungmann A, Wagner M, Burgis J, Vettel C, Katus HA, El-Armouche A, Müller OJ |
Gene Therapy | 2018 |
Functions and therapeutic potential of protein phosphatase 1: Insights from mouse genetics.
Ferreira M, Beullens M, Bollen M, Van Eynde A |
2018 | |
Chronic loss of inhibitor-1 diminishes cardiac RyR2 phosphorylation despite exaggerated CaMKII activity
S Neef, J Heijman, K Otte, M Dewenter, AR Saadatmand, S Meyer-Roxlau, CL Antos, J Backs, D Dobrev, M Wagner, LS Maier, A El-Armouche |
Naunyn-Schmiedeberg's Archives of Pharmacology | 2017 |
Redox regulation of the actin cytoskeleton and its role in the vascular system
Q Xu, LP Huff, M Fujii, KK Griendling |
Free radical biology & medicine | 2017 |
Negative Adrenergic Feedback Specific to Phospholamban ∗
G Hasenfuss, SE Lehnart |
JACC: Basic to Translational Science | 2017 |
Profiling analysis of long non-coding RNAs in early postnatal mouse hearts
X Sun, Q Han, H Luo, X Pan, Y Ji, Y Yang, H Chen, F Wang, W Lai, X Guan, Q Zhang, Y Tang, J Chu, J Yu, W Shou, Y Deng, X Li |
Scientific Reports | 2017 |
The role of Epac in the heart
T Fujita, M Umemura, U Yokoyama, S Okumura, Y Ishikawa |
Cellular and Molecular Life Sciences | 2016 |
Regulating the regulator: Insights into the cardiac protein phosphatase 1 interactome
DY Chiang, AJ Heck, D Dobrev, XH Wehrens |
Journal of Molecular and Cellular Cardiology | 2016 |
Counteracting Protein Kinase Activity in the Heart: The Multiple Roles of Protein Phosphatases
S Weber, S Meyer-Roxlau, M Wagner, D Dobrev, A El-Armouche |
Frontiers in pharmacology | 2015 |
Human G109E-inhibitor-1 impairs cardiac function and promotes arrhythmias
K Haghighi, TJ Pritchard, GS Liu, VP Singh, P Bidwell, CK Lam, E Vafiadaki, P Das, J Ma, S Kunduri, D Sanoudou, S Florea, E Vanderbilt, HS Wang, J Rubinstein, RJ Hajjar, EG Kranias |
Journal of Molecular and Cellular Cardiology | 2015 |
Up-regulation of micro-RNA765 in human failing hearts is associated with post-transcriptional regulation of protein phosphatase inhibitor-1 and depressed contractility: Up-regulation of micro-RNA765 in human failing hearts
WF Cai, GS Liu, CK Lam, S Florea, J Qian, W Zhao, T Pritchard, K Haghighi, D Lebeche, LJ Lu, J Deng, GC Fan, RJ Hajjar, EG Kranias |
European Journal of Heart Failure | 2015 |
Disruption of Epac1 decreases phosphorylation of phospholamban and protects the heart against stresses
Satoshi Okumura, Takayuki Fujita, Wenqian Cai, Meihua Jin, Iyuki Namekata, Yasumasa Mototani, Hui-Ling Jin, Yoshiki Ohnuki, Yayoi Tsuneoka, Reiko Kurotani, Kenji Suita, Yuko Kawakami, Shogo Hamaguchi, Takaya Abe, Hiroshi Kiyonari, Takashi Tsunematsu, Yunzhe Bai, Sayaka Suzuki, Yuko Hidaka, Masanari Umemura, Yasuhiro Ichikawa, Utako Yokoyama, Motohiko Sato, Fumio Ishikawa, Hiroko Izumi-Nakaseko, Satomi Adachi-Akahane, Hikaru Tanaka, Yoshihiro Ishikawa |
Journal of Clinical Investigation | 2014 |
Heart failure-specific changes in protein kinase signalling
K Lorenz, K Stathopoulou, E Schmid, P Eder, F Cuello |
Pflügers Archiv - European Journal of Physiology | 2014 |
Control of cytoplasmic and nuclear protein kinase A by phosphodiesterases and phosphatases in cardiac myocytes
ZH Slimane, I Bedioune, P Lechene, A Varin, F Lefebvre, P Mateo, V Domergue-Dupont, M Dewenter, W Richter, M Conti, A El-Armouche, J Zhang, R Fischmeister, G Vandecasteele |
Cardiovascular Research | 2014 |
Role of RyR2 Phosphorylation in Heart Failure and Arrhythmias: Controversies Around Ryanodine Receptor Phosphorylation in Cardiac Disease
D Dobrev, XH Wehrens |
Circulation research | 2014 |
p38α regulates SERCA2a function
L Kaikkonen, J Magga, VP Ronkainen, E Koivisto, Á Perjes, JK Chuprun, LE Vinge, T Kilpiö, J Aro, J Ulvila, T Alakoski, JA Bibb, I Szokodi, WJ Koch, H Ruskoaho, R Kerkelä |
Journal of Molecular and Cellular Cardiology | 2014 |
Development of phosphatase inhibitor-1 peptides acting as indirect activators of phosphatase 1.
Sotoud H, Borgmeyer U, Schulze C, El-Armouche A, Eschenhagen T |
Naunyn-Schmiedeberg's Archives of Pharmacology | 2014 |
Alterations in Ryanodine Receptors and Related Proteins in Heart Failure
S Ather, JL Respress, N Li, XH Wehrens |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2013 |
Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model
C Weber, I Neacsu, B Krautz, P Schlegel, S Sauer, P Raake, J Ritterhoff, A Jungmann, AB Remppis, M Stangassinger, WJ Koch, HA Katus, OJ Müller, P Most, ST Pleger |
Gene Therapy | 2013 |
Active inhibitor-1 maintains protein hyper-phosphorylation in aging hearts and halts remodeling in failing hearts
TJ Pritchard, Y Kawase, K Haghighi, A Anjak, W Cai, M Jiang, P Nicolaou, G Pylar, I Karakikes, K Rapti, J Rubinstein, RJ Hajjar, EG Kranias |
PloS one | 2013 |
Enhanced Ca²+ influx through cardiac L-type Ca²+ channels maintains the systolic Ca²+ transient in early cardiac atrophy induced by mechanical unloading
AP Schwoerer, S Neef, I Broichhausen, J Jacubeit, M Tiburcy, M Wagner, D Biermann, M Didié, C Vettel, LS Maier, WH Zimmermann, L Carrier, T Eschenhagen, T Volk, A El-Armouche, H Ehmke |
Pflügers Archiv : European journal of physiology | 2013 |
Age- and Gender-Related Changes in Ventricular Performance in Wild-Type FVB/N Mice as Evaluated by Conventional and Vector Velocity Echocardiography Imaging: A Retrospective Study
SE Koch, KJ Haworth, N Robbins, MA Smith, N Lather, A Anjak, M Jiang, P Varma, WK Jones, J Rubinstein |
Ultrasound in Medicine & Biology | 2013 |
Overexpression of cAMP-response element modulator causes abnormal growth and development of the atrial myocardium resulting in a substrate for sustained atrial fibrillation in mice
P Kirchhof, E Marijon, L Fabritz, N Li, W Wang, T Wang, K Schulte, J Hanstein, JS Schulte, M Vogel, N Mougenot, S Laakmann, L Fortmueller, J Eckstein, S Verheule, S Kaese, A Staab, S Grote-Wessels, U Schotten, G Moubarak, XH Wehrens, W Schmitz, S Hatem, FU Müller |
International Journal of Cardiology | 2013 |
Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy
C Kho, A Lee, RJ Hajjar |
Nature reviews. Cardiology | 2012 |
Constitutive phosphorylation of inhibitor-1 at Ser67 and Thr75 depresses calcium cycling in cardiomyocytes and leads to remodeling upon aging
S Florea, A Anjak, WF Cai, J Qian, E Vafiadaki, S Figueria, K Haghighi, J Rubinstein, J Lorenz, EG Kranias |
Basic Research in Cardiology | 2012 |
Modulation of Cardiac Contractility by the Phopholamban/SERCA2a Regulatome
EG Kranias, RJ Hajjar |
Circulation research | 2012 |
Heart Failure-Inducible Gene Therapy Targeting Protein Phosphatase 1 Prevents Progressive Left Ventricular Remodeling
Y Miyazaki, Y Ikeda, K Shiraishi, SN Fujimoto, H Aoyama, K Yoshimura, M Inui, M Hoshijima, H Kasahara, H Aoki, M Matsuzaki, P Rouet |
PloS one | 2012 |
Novel molecular targets for atrial fibrillation therapy
D Dobrev, L Carlsson, S Nattel |
Nature Reviews Drug Discovery | 2012 |
The relationship between the MMP system, adrenoceptors and phosphoprotein phosphatases
A Rietz, J Spiers |
British Journal of Pharmacology | 2012 |
Minimally invasive closed-chest ultrasound-guided substance delivery into the pericardial space in mice
S Laakmann, L Fortmüller, I Piccini, S Grote-Wessels, W Schmitz, G Breves, P Kirchhof, L Fabritz |
Naunyn-Schmiedeberg's Archives of Pharmacology | 2012 |
AAV9.I-1c delivered via direct coronary infusion in a porcine model of heart failure improves contractility and mitigates adverse remodeling
KM Fish, D Ladage, Y Kawase, I Karakikes, D Jeong, H Ly, K Ishikawa, L Hadri, L Tilemann, J Muller-Ehmsen, RJ Samulski, EG Kranias, RJ Hajjar |
Circulation. Heart failure | 2012 |
Impaired β-adrenergic responsiveness accentuates dysfunctional excitation–contraction coupling in an ovine model of tachypacing-induced heart failure
SJ Briston, JL Caldwell, MA Horn, JD Clarke, MA Richards, DJ Greensmith, HK Graham, MC Hall, DA Eisner, KM Dibb, AW Trafford |
The Journal of Physiology | 2011 |
The Inotropic Peptide βARKct Improves βAR Responsiveness in Normal and Failing Cardiomyocytes Through G βγ -Mediated L-Type Calcium Current Disinhibition
M Völkers, C Weidenhammer, N Herzog, G Qiu, K Spaich, F von Wegner, K Peppel, OJ Müller, S Schinkel, JE Rabinowitz, HJ Hippe, H Brinks, HA Katus, WJ Koch, AD Eckhart, O Friedrich, P Most |
Circulation research | 2011 |
In search of new therapeutic targets and strategies for heart failure: recent advances in basic science
AM Shah, DL Mann |
The Lancet | 2011 |
Calcium Cycling Proteins and Their Association With Heart Failure
L Hadri, RJ Hajjar |
Clinical Pharmacology & Therapeutics | 2011 |
Age-related regulation of excitation–contraction coupling in rat heart
HB Kandilci, E Tuncay, EN Zeydanli, NN Sozmen, B Turan |
Journal of Physiology and Biochemistry | 2011 |
Systematic Analysis of Gene Expression Differences between Left and Right Atria in Different Mouse Strains and in Human Atrial Tissue
PC Kahr, I Piccini, L Fabritz, B Greber, H Schöler, HH Scheld, A Hoffmeier, NA Brown, P Kirchhof |
PloS one | 2011 |
The Small Heat Shock Protein 20 (Hsp20) Interacts with Protein Phosphatase-1 and Enhances Sarcoplasmic Reticulum Ca-Cycling
J Qian, E Vafiadaki, SM Florea, VP Singh, W Song, CK Lam, Y Wang, Q Yuan, TJ Pritchard, W Cai, K Haghighi, P Rodriguez, HS Wang, D Sanoudou, GC Fan, EG Kranias |
Circulation research | 2011 |
Is ryanodine receptor phosphorylation key to the fight or flight response and heart failure?
Thomas Eschenhagen |
Journal of Clinical Investigation | 2010 |
The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implications
D Dobrev, N Voigt, XH Wehrens |
Cardiovascular Research | 2010 |
Phosphatase-1-inhibitor-1: amplifier or attenuator of catecholaminergic stress?
K Wittköpper, T Eschenhagen, A El-Armouche |
Basic Research in Cardiology | 2010 |
Expression of active protein phosphatase 1 inhibitor-1 attenuates chronic beta-agonist-induced cardiac apoptosis
G Chen, X Zhou, S Florea, J Qian, W Cai, Z Zhang, GC Fan, J Lorenz, RJ Hajjar, EG Kranias |
Basic Research in Cardiology | 2010 |